Picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses, according to a new study by researchers at the Indian Institute of Science ...
Jul 18, 2023
0
19
University of Pittsburgh researchers have shown for the first time how Merkel cell polyomavirus (MCV), which causes an aggressive skin cancer called Merkel cell carcinoma, initiates DNA replication in host cells.
Jul 17, 2023
0
20
As a result of the COVID-19 pandemic, respiratory syncytial virus (RSV) surges in young children occurred outside the usual November to March season, when immune-based prophylactic is available to protect children at high ...
Jul 14, 2023
0
18
Now that the emergency phase of the COVID-19 pandemic has ended, scientists are looking at ways to surveil indoor environments in real time for viruses. By combining recent advances in aerosol sampling technology and an ultrasensitive ...
Jul 10, 2023
0
126
Researchers at the Paul-Ehrlich-Institut (PEI), in cooperation with the Philipps-Universität Marburg, used the "recombinant measles vaccine virus" vaccine platform to test vaccine candidates against the dangerous avian H7N9 ...
Jul 7, 2023
0
44
Until now, scientific evidence has been inconclusive regarding the ability of SARS-CoV-2, the virus that causes COVID, to replicate in the human placenta. Answering this question, as well as understanding the response of ...
Jul 7, 2023
0
68
Researchers at Johns Hopkins Medicine, in collaboration with researchers at the National Institutes of Health, report that two new studies in mice with a humanized immune system and human cell lines have identified an enzyme ...
Jul 6, 2023
0
20
With a new method for examining virus samples researchers from the University of Copenhagen have solved an old riddle about how Hepatitis C virus avoids the human body's immune defenses. The result may have an impact on how ...
Jul 5, 2023
0
22
A large team of medical researchers and virus specialists at the University of Glasgow working with several colleagues from the University of Edinburgh and one from Istituto Zooprofilattico Sperimentale delle Venezie has ...
In a multicenter phase 3 trial, researchers at the MHH have demonstrated the efficacy and safety of the drug bulevirtide, which prevents HD viruses from entering the liver. This paves the way for a drug therapy of the particularly ...
Jun 22, 2023
0
12
